Do you want to change careers? Are you absolutely sure?
From my own career change to the stories I hear from my clients and workshop students, often we think we want to change careers when the problem is our work environment instead. If you find yourself stuck, unsure what to do next, or t
Investment company Asset Planning Services Inc buys Texas Instruments Inc, sells Eli Lilly and Co during the 3-months ended 2018-03-31, according to the most recent filings of the investment company, Asset Planning Services Inc . As of 2018-03-31, Asset Planning Services Inc owns 34 stocks with a total value of $128 million. These are the details of the buys and sells.
Another fatal crash involving a Tesla Inc. electric car is under scrutiny following Chief Executive Officer Elon Musk’s latest lashing-out over media coverage of his electric-car maker.
Police in southern Switzerland are investigating the death of a German man whose Tesla crashed into a guardrail and burst into flames last week, the Associated Press reported Tuesday. Bloomberg News....More>>>
There is a lot of news in the financial world, but tariffs seem to top the list. While the Trump administration’s new tariffs are all anyone can talk about right now, this is just the beginning of the story. It could end up being significant, or it could become trivial. We won’t know for sure for at least several weeks, until we have a chance to see exactly what the president decides....More>>>
WASHINGTON New Jersey won a landmark ruling from the Supreme Court Monday that could lead many states to legalize betting on college and professional sports.
The justices ruled 7-2 that a 25-year-old federal law that has effectively prohibitedsports betting outside Nevada by forcing states to keep prohibitions on the books is unconstitutional. The ruling could set the stage forother states....More>>>
General Motors (GM) just jumped after a short upbeat earnings call, and deservedly so, as it has lagged the market considerably since 2011. I’m going to take this opportunity to give CEO Barra some credit. A lot of exciting stuff is happening at General Motors, like 1) its operations are throwing off cash; 2) they are cutting loose underperforming parts; 3) there’s future optionality....More>>>
Field & Main Bank grew its stake in shares of Amgen (NASDAQ:AMGN) by 9.1% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,153 shares of the medical research company’s stock after buying an additional 345 shares during the quarter. Field & Main Bank’s holdings in Amgen were worth $708,000 at the....More>>>
Heart diseasestill claims the lives of around 600,000 Americans every year, and uncontrollable cholesterol plays a big role.EsperionTherapeutics Inc. (NASDAQ:ESPR)became oneof2017’s best-performing biotech stocks because it’s developing a drug that could lower this number.
Unfortunately, Esperion recently revealed some disturbing safety data from one of several ongoing late-stage....More>>>
Right now, there’s a major shift underway in the biotech field that’s creating a brand-new $59.2 billion industry. And investors who get in now could be positioning themselves for triple- or even quadruple-digit gains…
That’s why we’re bringing readers one of the best biotech stocks to buy in December 2017, according to Money Morning Director of Technology....More>>>
Victory Capital Management Inc. decreased its stake in Waste Management (NYSE:WM) by 13.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 57,987 shares of the business services provider’s stock after selling 8
Press coverage about GTT Communications (NYSE:GTT) has trended somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies
After updating investors on its wide-ranging gene therapy research program at a key industry conference early in the month,shares ofbluebird bio(NASDAQ:BLUE) surged 20.7% higher in January,according toS&P Global Market Intelligence.